Department of Ophthalmology, Yachiyo Medical Center, Tokyo Women's Medical University, Chiba, Japan.
Ophthalmologica. 2010;224(6):367-73. doi: 10.1159/000313819. Epub 2010 May 4.
The outcome of vitrectomy for macular edema was examined in patients with central retinal vein occlusion (CRVO), as well as whether vascular endothelial growth factor (VEGF) and interleukin-6 (IL-6) levels in vitreous fluid influence the visual prognosis and macular edema. Twenty-six consecutive patients with CRVO and macular edema underwent vitrectomy. Best-corrected visual acuity, retinal thickness, and the VEGF and IL-6 levels in vitreous fluid were measured before and after surgery. Both visual acuity and retinal thickness were significantly improved at 6 months postoperatively (p = 0.0114 and p < 0.0001, respectively). The vitreous VEGF level was significantly higher in patients who showed less improvement of visual acuity (p = 0.0182). In contrast, a high vitreous VEGF level was associated with greater improvement of macular edema (p = 0.0199). These results suggest that the vitreous VEGF level may be correlated with the visual prognosis and changes of macular edema in CRVO patients after vitrectomy.
我们研究了玻璃体内血管内皮生长因子(VEGF)和白细胞介素-6(IL-6)水平对视网膜中央静脉阻塞(CRVO)患者行玻璃体切割术后视力预后和黄斑水肿的影响。26 例 CRVO 合并黄斑水肿患者接受了玻璃体切割术。手术前后测量最佳矫正视力、视网膜厚度以及玻璃体液中 VEGF 和 IL-6 水平。术后 6 个月视力和视网膜厚度均显著改善(p = 0.0114 和 p < 0.0001)。玻璃体液 VEGF 水平在视力改善较少的患者中显著升高(p = 0.0182)。相反,玻璃体液 VEGF 水平较高与黄斑水肿的改善程度较大相关(p = 0.0199)。这些结果表明,玻璃体液 VEGF 水平可能与 CRVO 患者玻璃体切割术后的视力预后和黄斑水肿变化相关。